109 related articles for article (PubMed ID: 17653128)
41. A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia.
Takizawa S; Izuhara Y; Kitao Y; Hori O; Ogawa S; Morita Y; Takagi S; van Ypersele de Strihou C; Miyata T
Brain Res; 2007 Dec; 1183():124-37. PubMed ID: 17976543
[TBL] [Abstract][Full Text] [Related]
42. Neuroprotective effects of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats.
Sharma SS; Kaundal RK
Neurol Res; 2007 Apr; 29(3):304-9. PubMed ID: 17509231
[TBL] [Abstract][Full Text] [Related]
43. Cell death mechanism and protective effect of erythropoietin after focal ischemia in the whisker-barrel cortex of neonatal rats.
Wei L; Han BH; Li Y; Keogh CL; Holtzman DM; Yu SP
J Pharmacol Exp Ther; 2006 Apr; 317(1):109-16. PubMed ID: 16357210
[TBL] [Abstract][Full Text] [Related]
44. Neuroprotective effects of leptin against ischemic injury induced by oxygen-glucose deprivation and transient cerebral ischemia.
Zhang F; Wang S; Signore AP; Chen J
Stroke; 2007 Aug; 38(8):2329-36. PubMed ID: 17600230
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of N-myc downstream-regulated gene-2 is involved in an astrocyte-specific neuroprotection induced by sevoflurane preconditioning.
Li X; Luo P; Wang F; Yang Q; Li Y; Zhao M; Wang S; Wang Q; Xiong L
Anesthesiology; 2014 Sep; 121(3):549-62. PubMed ID: 24866406
[TBL] [Abstract][Full Text] [Related]
46. Neuroprotection with intraventricular brain-derived neurotrophic factor in rat venous occlusion model.
Takeshima Y; Nakamura M; Miyake H; Tamaki R; Inui T; Horiuchi K; Wajima D; Nakase H
Neurosurgery; 2011 May; 68(5):1334-41. PubMed ID: 21307800
[TBL] [Abstract][Full Text] [Related]
47. Necrosis, apoptosis and hybrid death in the cortex and thalamus after barrel cortex ischemia in rats.
Wei L; Ying DJ; Cui L; Langsdorf J; Yu SP
Brain Res; 2004 Oct; 1022(1-2):54-61. PubMed ID: 15353213
[TBL] [Abstract][Full Text] [Related]
48. Neuroprotectant FK506 inhibits glutamate-induced apoptosis of astrocytes in vitro and in vivo.
Szydlowska K; Zawadzka M; Kaminska B
J Neurochem; 2006 Nov; 99(3):965-75. PubMed ID: 17076660
[TBL] [Abstract][Full Text] [Related]
49. VEGF protects brain against focal ischemia without increasing blood--brain permeability when administered intracerebroventricularly.
Kaya D; Gürsoy-Ozdemir Y; Yemisci M; Tuncer N; Aktan S; Dalkara T
J Cereb Blood Flow Metab; 2005 Sep; 25(9):1111-8. PubMed ID: 15829918
[TBL] [Abstract][Full Text] [Related]
50. Protection against ischemic brain damage by GDNF affecting cell survival and death signals.
Jin G; Omori N; Li F; Nagano I; Manabe Y; Shoji M; Abe K
Neurol Res; 2003 Apr; 25(3):249-53. PubMed ID: 12739232
[TBL] [Abstract][Full Text] [Related]
51. Effect of propofol on calcium homeostasis in hypoxia-reoxygenated neonatal rat cardiomyocytes.
Kim HS; Chang WC; Hwang KC; Choi IG; Park WK
Eur J Pharmacol; 2008 Oct; 594(1-3):139-45. PubMed ID: 18674530
[TBL] [Abstract][Full Text] [Related]
52. Neuroprotective effects of ginsenoside Rb1 on transient cerebral ischemia in rats.
Yuan QL; Yang CX; Xu P; Gao XQ; Deng L; Chen P; Sun ZL; Chen QY
Brain Res; 2007 Sep; 1167():1-12. PubMed ID: 17663984
[TBL] [Abstract][Full Text] [Related]
53. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
[TBL] [Abstract][Full Text] [Related]
54. Propofol: an immunomodulating agent.
Marik PE
Pharmacotherapy; 2005 May; 25(5 Pt 2):28S-33S. PubMed ID: 15899746
[TBL] [Abstract][Full Text] [Related]
55. The neuroprotective effect of propofol against brain ischemia mediated by the glutamatergic signaling pathway in rats.
Cai J; Hu Y; Li W; Li L; Li S; Zhang M; Li Q
Neurochem Res; 2011 Oct; 36(10):1724-31. PubMed ID: 21556843
[TBL] [Abstract][Full Text] [Related]
56. Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space.
Fukada T; Ozaki M
Anaesthesia; 2007 Jun; 62(6):575-80. PubMed ID: 17506735
[TBL] [Abstract][Full Text] [Related]
57. The safety and efficacy of propofol containing EDTA: a randomised clinical trial programme focusing on cation and trace metal homeostasis in critically ill patients.
Zaloga GP; Teres D
Intensive Care Med; 2000; 26 Suppl 4():S398-9. PubMed ID: 11310901
[No Abstract] [Full Text] [Related]
58. Propofol anesthesia compared to awake reduces infarct size in rats.
Gelb AW; Bayona NA; Wilson JX; Cechetto DF
Anesthesiology; 2002 May; 96(5):1183-90. PubMed ID: 11981160
[TBL] [Abstract][Full Text] [Related]
59. Propofol Attenuates α-Synuclein Aggregation and Neuronal Damage in a Mouse Model of Ischemic Stroke.
Wang Y; Tian D; Wei C; Cui V; Wang H; Zhu Y; Wu A; Yue Y
Neurosci Bull; 2020 Mar; 36(3):289-298. PubMed ID: 31520398
[TBL] [Abstract][Full Text] [Related]
60. High molecular weight hyaluronan decreases oxidative DNA damage induced by EDTA in human corneal epithelial cells.
Ye J; Wu H; Wu Y; Wang C; Zhang H; Shi X; Yang J
Eye (Lond); 2012 Jul; 26(7):1012-20. PubMed ID: 22595911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
